Protocol for the systematic review of mathematical modelling studies describing the progression from Chlamydia trachomatis and Neisseria gonorrhoeae to Pelvic inflammatory Disease
Background
Pelvic inflammatory disease (PID) is the most common direct complication of sexually transmitted Chlamydia trachomatis (chlamydia) and Neisseria gonorrhoeae (gonorrhoea) infections in women. 1 PID occurs when microorganisms ascend from the vagina and/or endocervix to the upper genital tract, including endometrium, fallopian tubes and contiguous structures. 2 Inflammation and scarring in the fallopian tubes is a strong risk factor for subsequent ectopic pregnancy and tubal infertility. 3 The link between 'latent gonorrhoea', pelvic inflammation and infertility was first suggested in the late 19 th century 4 and gonorrhoea was the subject of the first mathematical modelling studies examining the impact of sexually transmitted infections on fertility. 5 Screening to detect and treat asymptomatic chlamydia, which is now the most common notifiable sexually transmitted infection in the U.S., 2 is recommended to prevent PID. 6, 7 Screening programmes could work either by identifying and treating infections before they progress to PID and/or reducing transmission and hence exposure to the causative agent. 8 The timing of progression from infection to PID could influence the potential impact of a screening programme but there is no agreement on when sexually transmitted infections ascend to the upper genital tract.
Mathematical modelling can be used to investigate processes and mechanisms that are difficult to observe in practice. 9 Publications using models to investigate the potential impact of screening strategies on PID incidence should provide a source of information about assumptions about the timing of progression from infection to PID.
A systematic review will be beneficial to understand how other researchers have conceptualised progression from chlamydia or gonorrhoea to PID, especially the timing of progression. We are interested in what kinds of models have described both chlamydia or gonorrhoea infection dynamics and progression to PID. This will help us to improve our own modelling work and to gives us an overview which parameters have been used.
Objective
To conduct a systematic review to determine how the natural history of C. trachomatis or N. gonorrhoeae infection and progression to PID have been described in mathematical modelling studies
Methods
In this section we set out the research questions and the methods for preparing the systematic review.
Questions
Questions to be answered by the systematic review:
• How is the natural history of chlamydia and gonorrhoea described in reports of modelling studies? • What are the estimates used about progression from chlamydia/gonorrhoea to PID and its consequences (rates or probabilities) and their range? • How is the timing of progression from chlamydia/gonorrhoea to PID described?
• How are the consequences of PID, such as ectopic pregnancy and infertility, described?
Inclusion criteria
We will search for publications in which C. trachomatis or N. gonorrhoeae are modelled (compartments/individual based) and PID is included in the model or the progression probability is described in a decision tree.
Study types
We will consider the following study types for inclusion:
• Mathematical models • Economic evaluations
Population
We will consider following populations:
• Women or men
Intervention
Not essential for inclusion, but if included we will extract information about following interventions in the model:
Outcomes reported
One or more of the following:
• Progression to PID • PID is included directly in the model of the infection (as a compartment or a status in an individual based model) or has a decision tree attached to the model
Exclusion criteria
We will exclude publications if one or more of the following is applicable:
• Models with only men as a population that do not consider complications in women • Animal models • No progression to PID considered, e.g. cost of illness studies • Studies reporting on PID as a complication of contraceptive methods such as intrauterine device (IUD) • If progression to PID is described with probabilities in a decision tree but no graphical illustration of the decision tree is shown
Search strategy

Electronic databases
The following databases will be searched from the earliest date of the databank to 19. October 2009 without language restrictions:
• The Cochrane Library
Search terms
There is no single Medical Subject Heading search term in Medline for mathematical modelling studies. Search strategies will use subject headings specific to each database and free text search that combine terms for • Mathematical models • Pelvic inflammatory disease For details see appendix (Appendix 1: Search strategies).
Additional searches
The following additional searches will be done:
• Reference lists of included publications will be screened • For included publications where a reference is given for the used model we will retrieve the original • Experts in the field will be contacted for publications that might fit our inclusion criteria
Selection of eligible studies
Two suitably qualified reviewers will review the lists of articles identified by the search strategy independently using the inclusion and exclusion criteria listed in paragraphs 3.2. and 3.3. Any study selected as being potentially eligible by either reviewer, will be retained for review of the full text.
Potentially eligible studies
The reviewers will read the abstract of each identified article if fewer than 500 articles are returned in total. If the searches identify 500 or more articles, the reviewers will select potentially eligible titles first and will then read the abstracts of titles that potentially fit the inclusion criteria. If no abstract is available electronically, the full text of the article will be requested. The abstracts of articles identified through additional searches (paragraph Additional searches) will be reviewed in the same manner as for studies identified through database searches.
Retrieval of full-text articles
We will obtain the full text of articles or other documents reporting studies identified as being potentially eligible for inclusion. We will make every effort to locate documents through internet downloads, inter-library loans and contacting authors of reviews citing potentially eligible documents. We will request translation if necessary to confirm or refute eligibility.
Selection of studies for inclusion
The two independent reviewers will examine full text articles and compare their lists of studies eligible for inclusion. Studies identified by both reviewers as being eligible for inclusion and having adequate data for extraction will be included in the review. Where there are discrepancies, the reasons for these will be discussed and a decision about inclusion reached by consensus. If there is no agreement, a third independent reviewer will adjudicate to make a final decision about eligibility.
Data extraction forms
We will develop forms for extracting consistent data about:
• Description of the natural history of chlamydia and gonorrhoea in models • Type of model for the infection and for PID • Is symptomatic and asymptomatic PID considered • Rate or probability of progression from infection to PID and the considered range (e.g. confidence interval, range used in sensitivity analysis) • When during infection progression to PID happens and how is this implemented in the model • Duration of PID status and considered range if applicable • What are the references for parameters about PID: modelling paper or clinical data • Which complications are considered and how are they implemented (chronic pelvic pain, ectopic pregnancy, infertility, neonatal pneumonia, neonatal conjunctivitis, epididymitis) • Methodological and reporting quality (see paragraph 3.12.)
Data extraction forms will be designed to capture any information for the outcomes listed in paragraph 3.2.4. as well as any specific data for more restricted forms of outcome definitions which may be used in analysis.
We will pilot test the forms to ensure ease of use and capture of all relevant data. The forms will be developed using Epidata (Epidata version 3.1, EpiData Association, Odense, Denmark).
Data extraction
Two appropriately qualified people will extract and enter data independently from each included study into Epidata. Articles in languages other than English will either be translated first and then duplicate data extraction conducted as above or, if there are two reviewers who understand the language of publication, they will extract the data directly.
The two files will be compared using the validation function available in this program. Discrepancies in data extraction or data entry will be resolved by consensus. If there is no agreement a third independent reviewer will adjudicate to make a final decision.
Studies might be excluded at the data entry stage if it becomes apparent that inclusion criteria are not met or there is not enough information in the documents to extract the required data.
Data analysis
The data analysis will be descriptive including:
• A flow chart describing included and excluded publications • A table with the characteristics of the included publications • For the publications with a decision tree an overview of the used probabilities of progression • For the publications with models other than decision trees an overview about the model characteristics, specially the parameters about PID • A table with an overview about the conceptualised progression from chlamydia or gonorrhoea to PID
Assessment of quality of reporting
We will search for checklists of items associated with methodological and reporting quality that are specific to modelling papers -if not, define our own:
• Is a flow diagram of model shown?
• Are values for all parameters used in the model stated and referenced?
• Is the unit of each parameter clearly stated (e.g. rate or probability)?
• Is it stated in which languages/programme the model is implemented?
• Does each branch in a decision tree some up to 1 if probabilities are used?
• Has a sensitivity analysis be done?
Write report
Reports will be written following the appropriate guidelines (e.g. PRISMA Guidelines for reporting of meta-analyses and systematic reviews) and will clearly present the methods used as well as findings.
